Non-islet cell tumour-associated hypoglycaemia: 111In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids

Clinical Endocrinology

Volumn 44, Issue 6, 1996, Pages 727-731

  Perros, Petros ^a,c   Simpson, John ^a   Alistair Innes, J ^a   Derrick Teale, J ^b   McKnlght, John A ^a  

^a NHS LOTHIAN   (United Kingdom)

^b St Luke's Hospital Guildford   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENDROFLUMETHIAZIDE; GROWTH HORMONE; OCTREOTIDE; PREDNISOLONE;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPOGLYCEMIA; MESENCHYMOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030008986     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.721542.x     Document Type: Article

References (17)

1. Baxter, R.C. & Martin, J.L. (1986) Radioimmunoassay of growth hormone-dependent insulin like growth factor binding protein in human plasma. Journal of Clinical Investigation, 78, 1504-1512.
2. Baxter, R.C & Daughaday, W.H (1991) Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to non-islet cell tumors. Journal of Clinical Endocrinology and Metabolism, 73, 696-702.
3. Baxter, R.C., Holman, S.R., Corbould, A., Stranks, S., Ho, J.P. & Braund, W. (1995) Regulation of the insulin-like growth factors and their binding proteins by glucocorticosteroid and growth hormone in nonislet cell tumour hypoglycemia. Journal of Clinical Endocrinology and Metabolism, 80, 2700-2708.
4. Briselli, M., Mark, E. & Dickerson, R. (1981) Solitary tumours of the pleura: eight new cases and review of 360 cases in the literature. Cancer, 47, 2678-2689.
5. Daughaday, W.H. & Trivedi, B (1992) Measurement of the derivatives of pro-insulin-like growth factor II in serum by radioimmunoassay directed against the E-domain in normal subjects and patients with non-islet cell tumor hypoglycemia. Journal of Clinical Endocrinology and Metabolism, 75, 110-115.
6. Daughaday, W.H., Trivedi, B & Baxter, R.C. (1993) Serum 'big' insulin-like growth factor II (IGF-II) from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proceedings of the National Academy of Sciences, 90, 5823-5827.
7. Gerich, J.E. & Bolli, G.B. (1993) Counterregulatory failure. In Hypoglycemia and Diabetes: Clinical and Physiological Aspects (eds B. M. Frier & B. M. Fisher), pp. 253-267. Edward Arnold, London.
8. Hunter, S.J., Daughaday, W.H., Callender, M.E., McKnight, J.A., Mcllrath, E.M., Teale, J.D. & Atkinson, A.B. (1994) A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin. Clinical Endocrinology, 41, 397-401.
9. Kubota, A., Yamada, Y, Kagimoto, S., Shimatsu, A, Imamura, M., Tsuda, K, Imura, H., Seino, S. & Seino, Y. (1994) Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. Journal of Clinical Investigation, 93, 1321-1325.
10. Lamberts, S.W.J., Krenning, E.P. & Reubi, J-C. (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumours. Endocrine Reviews, 12, 450-482.
11. Laron, Z. (1990) Somatostatin analogues in the management of benign insulinomas. Israel Journal of Medical Science, 26, 1-2.
12. Marks, V. & Teale, J.D. (1993) Hypoglycaemia in the adult. Bailliere's Clinics in Endocrinology and Metabolism, 7, 705-729.
13. Mitrakou, A., Fanelli, C., Veneman, T., Perrielo, G., Calderone, S., Platanisiotis, D., Rambotti, A., Raptis, S., Brunetti, P., Cryer, P., Gerrich, J. & Bolli, G. (1993) Reversibility of unawareness of hypoglycemia in patients with insulinomas. New England Journal of Medicine, 329, 834-839.
14. Sakamoto, T., Kaneshige, A., Taseshi, A., Tsushima, T. & Hasegawa, S. (1994) Localized pleural mesothelioma with elevation of high molecular weight insulin-like growth factor II and hypoglycemia. Chest, 106, 965-967.
15. Samaan, N.A., Pham, F.K., Sellin, R.V. et al. (1990) Successful treatment of hypoglycemia using glucagon in a patient with an extrahepatic tumour. Annals of Internal Medicine, 113, 404-406.
16. Teale, J.D. & Marks, V (1990) Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia. Clinical Endocrinology, 33, 87-98.
17. Teale, J.D., Blum, W.F. & Marks, V. (1992) Alleviation of non-islet cell tumour hypoglycaemia with growth hormone therapy is associated with changes in IGF binding protein-3. Annals of Clinical Biochemistry, 29, 314-323.